CRESCENT BIOPHARMA, INC. Accounts Payable
CRESCENT BIOPHARMA, INC. (CBIO) had Accounts Payable of $104.67 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-05-14
- 2025-03-31: Accounts Payable, Current $104.67K.
- 2024-12-31: Accounts Payable, Current $329.30K.
- 2024-09-30: Accounts Payable, Current $581.79K.
- 2024-06-30: Accounts Payable, Current $950.76K.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-03-31 | $104.67K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $329.30K 10-Q · filed 2025-05-14 |
| 2024-09-30 | $581.79K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $950.76K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $755.53K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $868.12K 10-K · filed 2025-02-13 |
| 2023-09-30 | $329.88K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $241.49K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $480.15K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $970.19K 10-K · filed 2024-03-27 |
| 2022-09-30 | $852.13K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.27M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $2.28M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $2.11M 10-K · filed 2023-03-29 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.14M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $2.09M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.07M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.37M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $3.13M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $1.44M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.41M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.03M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.87M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $2.66M 10-K · filed 2020-02-28 |
| 2018-09-30 | $659.39K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $3.24M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $3.85M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $2.65M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.63M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $575.11K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $511.71K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.57M 10-K · filed 2018-03-06 |
| 2016-09-30 | $1.25M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $1.40M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.62M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $564.24K 10-K · filed 2017-03-01 |
| 2015-09-30 | $633.09K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.11M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.18M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $874.03K 10-K · filed 2016-02-29 |
| 2014-09-30 | $583.72K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $472.16K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $1.80M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $1.14M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |